Kenny Yeo

Kenny Yeo

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences


    Expand
  • Awards and Achievements

    Date Type Title Institution Name Country Amount
    2021 Scholarship University of Adelaide-Nottingham Joint-PhD Scholarship University of Adelaide Australia
    2020 Scholarship The Hospital Research Foundation Honours Research Scholarship University of Adelaide Australia
  • Language Competencies

    Language Competency
    Chinese (Mandarin) Can read, write, speak and understand spoken
    English Can read, write, speak and understand spoken
  • Education

    Date Institution name Country Title
    2021 - 2024 University of Adelaide Australia PhD in Medicine
    2020 - 2020 University of Adelaide Australia Bachelor of Health and Medical Sciences (Honours)
    2016 - 2018 University of Western Australia Australia Bachelor of Science, Biomedical Science
    Expand
  • Journals

    Year Citation
    2021 Tomita, Y., Smith, E., Palethorpe, H. M., Nakhjavani, M., Yeo, K. K. L., Townsend, A. R., . . . Hardingham, J. E. (2021). In vitro synergistic inhibition of HT-29 proliferation and 2H-11 and HUVEC tubulogenesis by bacopaside I and II Is associated with Ca²⁺ flux and loss of plasma membrane integrity. Pharmaceuticals, 14(5), 436.
    DOI
    2021 Nakhjavani, M., Smith, E., Yeo, K., Palethorpe, H. M., Tomita, Y., Price, T. J., . . . Hardingham, J. E. (2021). Anti-angiogenic properties of ginsenoside rg3 epimers: In vitro assessment of single and combination treatments. Cancers, 13(9), 20 pages.
    DOI Scopus2 WoS1 Europe PMC1
    2021 Nakhjavani, M., Smith, E., Yeo, K., Tomita, Y., Price, T. J., Yool, A., . . . Hardingham, J. E. (2021). Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3. Journal of Ginseng Research.
    DOI
    2021 Nakhjavani, M., Smith, E., Palethorpe, H. M., Tomita, Y., Yeo, K., Price, T. J., . . . Hardingham, J. E. (2021). Anti-cancer effects of an optimised combination of ginsenoside rg3 epimers on triple negative breast cancer models. Pharmaceuticals, 14(7), 20 pages.
    DOI

Connect With Me
External Profiles